FDA Rejects Sunscreen TEAs, Plans Public Hearing On Ingredient Review
This article was originally published in The Tan Sheet
Executive Summary
Answering time-and-extent applications, FDA finds data insufficient to affirm the safety of amiloxate and diethylhexyl butamido triazone as sunscreen ingredients. The agency asks for further information in support of the ingredients’ safety and plans a public meeting on its evaluation of OTC sunscreen ingredients.